Navidea Biopharmaceuticals Limited - Abbreviated accounts 16.3

REGISTERED NUMBER: 07711916 (England and Wales)

ABBREVIATED UNAUDITED ACCOUNTS FOR THE YEAR ENDED 31 JULY 2016

FOR

NAVIDEA BIOPHARMACEUTICALS LIMITED

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

3

DIRECTOR:

W J Regan

REGISTERED OFFICE:

30 Upper High Street

Thame

Oxfordshire

OX9 3EZ

REGISTERED NUMBER:

07711916 (England and Wales)

ACCOUNTANTS:

Richardsons

Chartered Accountants

30 Upper High Street

Thame

Oxfordshire

OX9 3EZ

CURRENT ASSETS

Debtors

1

TOTAL ASSETS LESS CURRENT
LIABILITIES

1

CAPITAL AND RESERVES

Called up share capital

2

1

SHAREHOLDERS' FUNDS

1

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2016 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the director on 13 April 2017 and were signed by:

W J Regan - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance

with the Financial Reporting Standard for Smaller Entities (effective January 2015).

The company was dormant throughout the current year and previous year.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at

the balance sheet date.

2.	CALLED UP SHARE CAPITAL

Allotted and issued:

Number:

Class:

Nominal

2016

2015

value:

£

1

Share capital 1

1

-

100

Share capital 2

0.01

1

3.	ULTIMATE PARENT COMPANY

Navidea Biopharmaceuticals Inc (incorporated in USA ) is regarded by the director as being the

company's ultimate parent company.

Parent company accounts may be obtained from the following address;

5600 Blazer Parkway

Suite 200

Dublin

OH 43017